GlassScriptPhysician profile
Kent C Sasse
NPI 1538104443
$43,711.45
in general payments reported to CMS, 2019-2025
29 companies · $1,821 in 2025
The $1,821 reported for 2025 was more than what 81% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $15K · 2021: $395 · 2022: $1,788 · 2023: $644 · 2024: $554 · 2025: $1,821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,681 · Travel and Lodging: $1,337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,681.35 |
| Travel and Lodging | $1,336.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $31,639.24 | 2019-2020 | |
| Baxter Healthcare | $4,430.42 | 2019-2024 | Perclot |
| Palette Life Sciences, INC. | $2,796.30 | 2020-2022 | |
| Medtronic, INC. | $2,022.29 | 2022-2025 | Ligasure, Signia |
| Teleflex LLC | $857.41 | 2023-2025 | Titan Sgs, Titan Sgs Standard Gastric Stapler, Titan Sgs Bailout Chuck |
| Axonics, INC. | $396.78 | 2020-2023 | Axonics |
| Organogenesis INC. | $358.98 | 2020-2023 | Puraply |
| Intuitive Surgical, INC. | $156.05 | 2022 | |
| Novo Nordisk INC | $142.28 | 2020-2024 | Wegovy |
| Tela Bio, INC. | $131.46 | 2019-2024 | Ovitex 2s |
| Boston Scientific Corporation | $130.81 | 2019-2024 | |
| Ethicon US, LLC | $122.54 | 2022 | |
| Standard Bariatrics, INC. | $110.29 | 2022 | |
| Tactile Systems Technology INC | $60.47 | 2019-2024 | Flexitouch Plus, Entre Plus |
| Becton, Dickinson and Company | $47.61 | 2023-2024 | Phasix Mesh, Optifix Open Absorbable Fixation System |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $35.23 | 2019-2020 | |
| Baudax Bio INC. | $31.93 | 2020-2022 | |
| Nevro Corp. | $29.71 | 2021 | |
| Si-Bone, INC. | $26.48 | 2025 | |
| Sanara Medtech INC. | $25.00 | 2023 | Celleraterx |
| Kerecis Limited | $23.88 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Kci USA, INC. | $21.90 | 2019 | |
| Paratek Pharmaceuticals, INC. | $21.32 | 2020 | |
| Biom'Up France Sas | $21.29 | 2021 | |
| Acacia Pharma INC | $18.79 | 2021 | |
| W. L. Gore & Associates, INC. | $16.40 | 2019 | |
| Smith+Nephew, INC. | $16.18 | 2022 | |
| Nalpropion Pharmaceuticals LLC | $13.17 | 2019 | |
| Ambu INC. | $7.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kent Sasse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.